Company Monitoring Page for Gilead-Sciences

latest headlines for company on cafepharma

Humana, Centene sue drugmakers, alleging anticompetitive practices on HIV drugs
BioPharma Dive
Thu, 12/16/21 - 10:45 am
Tags:
Humana, Centene, generics, anticompetitive practices, Gilead Sciences, Bristol Myers Squibb, JNJ, Teva Pharmaceuticals
ASH: Bristol Myers' Breyanzi, Gilead's Yescarta lock horns in race to move CAR-T therapy to earlier lymphoma
Fierce Pharma
Sat, 12/11/21 - 09:22 pm
Tags:
Gilead Sciences, Yescarta, Bristol Myers Squibb, Breyanzi, CAR-T, lymphoma
Digital pill tracks HIV PrEP adherence with 98% accuracy
Pharmaforum
Thu, 12/9/21 - 10:38 am
Tags:
digital pills, HIV, PrEP, Gilead Sciences
AZ, Daiichi take aim at Gilead in triple-negative breast cancer
Pharmaforum
Wed, 12/8/21 - 10:37 am
Tags:
AstraZeneca, Daiichi Sankyo, Gilead Sciences, Trodelvy, triple negative breast cancer, Dato-DXd
Gilead recalls 2 lots of COVID-19 drug Veklury after finding glass particulates in vials
Fierce Pharma
Mon, 12/6/21 - 10:38 am
Tags:
Gilead Sciences, product recalls, Veklury, COVID-19, drug manufacturing
Mei, with Bayer and Gilead in its sights, posts pivotal data on blood cancer prospect
Fierce Biotech
Tue, 11/30/21 - 10:41 am
Tags:
MEI Pharma, blood cancer, follicular lymphoma, zandelisib, Bayer, Gilead Sciences
Gilead files first hepatitis delta therapy with FDA
Pharmaforum
Mon, 11/22/21 - 10:25 am
Tags:
Gilead Sciences, buleviritide, antivirals, hepatitis delta, FDA
Why Arcus Biosciences Stock Is On Fire Today
Motley Fool
Thu, 11/18/21 - 10:41 am
Tags:
Arcus Biosciences, Gilead Sciences, anti-TIGIT, etrumadenant, quemliclustat
Despite strong quarter, some wonder how long Gilead can rely on coronavirus drug
BioPharma Dive
Fri, 10/29/21 - 11:17 am
Tags:
Gilead Sciences, earnings, Veklury, remdesivir, COVID-19
Gilead Sciences : Study Data Of Biktarvy In People Living With HIV Show High Effectiveness
NASDAQ
Fri, 10/29/21 - 11:05 am
Tags:
Gilead Sciences, Biktarvy, HIV, RWE
Gilead, Merck to study combination therapy for breast cancer
Pharmaceutical Business Review
Fri, 10/29/21 - 10:56 am
Tags:
Gilead Sciences, Merck, Trodelvy, Keytruda, triple negative breast cancer
Gilead taps brakes on $4.9B bet after rival's failure, pushing blood cancer data out to 2022
Fierce Biotech
Fri, 10/29/21 - 10:35 am
Tags:
Gilead Sciences, Forty Seven, magrolimab, MDS
Can Merck's Antiviral for COVID Succeed Where Gilead's Failed?
Motley Fool
Sun, 10/24/21 - 10:32 pm
Tags:
Merck, antivirals, COVID-19, Gilead Sciences
Kite gets US FDA approval for Tecartus to treat acute lymphoblastic leukemia
Pharmaceutical Business Review
Mon, 10/4/21 - 10:39 am
Tags:
Kite Pharma, Gilead Sciences, Tecartus, FDA, ALL, acute lymphoblastic leukemia
Gilead, Bristol Myers face lawsuit from major pharmacies over HIV generic drug delays
Endpoints
Wed, 09/29/21 - 11:01 am
Tags:
Gilead Sciences, Teva Pharmaceutical, Bristol Myers Squibb, CVS, Rite Aid, generics, HIV
Oncology the focus for big pharma catalysts
EP Vantage
Tue, 09/28/21 - 11:19 am
Tags:
Big Pharma, cancer, oncology, Merck, Keytruda, AbbVie, Vraylar, Gilead Sciences, Trodelvy, Sanofi, Sarclisa, Novartis, ligelizumab
Remdesivir reduces Covid hospitalizations when given early, study shows
Stat
Wed, 09/22/21 - 11:20 am
Tags:
Gilead Sciences, remdesivir, COVID-19
Gilead keeps pushing trove of Trodelvy data as it seeks to become new standard of care in TNBC
Endpoints
Thu, 09/16/21 - 10:42 am
Tags:
ESMO, Gilead Sciences, Trodelvy, triple negative breast cancer
ESMO Preview: Highlights to Watch for This Year
BioSpace
Wed, 09/15/21 - 10:29 pm
Tags:
ESMO, oncology, cancer, Gilead Sciences, Bristol Myers Squibb, Zymeworks, Amgen, Adaptimmune Therapeutics, TCR2 Therapeutics, Boehringer Ingelheim
Could Moderna Take Down Gilead Sciences?
Motley Fool
Mon, 08/30/21 - 10:52 am
Tags:
Moderna Therapeutics, HIV, vaccines, MRNA, Gilead Sciences

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.